To study the relationship of race, socioeconomic status (SES), clinical factors, and psychosocial factors to outcomes in patients with systemic lupus erythematosus (SLE).
A retrospective cohort was assembled, comprising 200 patients with SLE from 5 centers.
This cohort was balanced in terms of race and SES.
Patients provided information on socioeconomic factors, access to health care, nutrition, self-efficacy for disease management, health locus of control, social support, compliance, knowledge about SLE, and satisfaction with medical care.
Outcome measures included disease activity (measured by the Systemic Lupus Activity Measure), damage (measured by the SLICC/ACR damage index), and health status (measured by the SF-36).
In multivariate models that were controlled for race, SES, center, psychosocial factors, and clinical factors, lower self-efficacy for disease management (P ¾ 0.0001), less social support (P<0.005), and younger age at diagnosis (P<0.007) were associated with greater disease activity.
Older age at diagnosis (P ¾ 0.0001), longer duration of SLE (P ¾ 0.0001), poor nutrition (P<0.002), and higher disease activity at diagnosis (P<0.007) were associated with more damage.
Lower self-efficacy for disease management was associated with worse physical function (P ¾ 0.0001) and worse mental health status (P ¾ 0.0001).
Mots-clés Pascal : Lupus érythémateux, Disséminé, Homme, Facteur risque, Pronostic, Ethnie, Statut socioéconomique, Analyse multivariable, Evolutivité, Aspect social, Etats Unis, Amérique du Nord, Amérique, Epidémiologie, Etude cohorte, Etude multicentrique, Peau pathologie, Tissu conjonctif pathologie, Maladie système, Maladie autoimmune, Immunopathologie
Mots-clés Pascal anglais : Lupus erythematosus, Disseminated, Human, Risk factor, Prognosis, Ethnic group, Socioeconomic status, Multivariate analysis, Evolutivity, Social aspect, United States, North America, America, Epidemiology, Cohort study, Multicenter study, Skin disease, Connective tissue disease, Systemic disease, Autoimmune disease, Immunopathology
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0151241
Code Inist : 002B07. Création : 21/05/1997.